Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulphate and dexmedetomidine for cerebral oxygenation during shoulder surgery
PACTR202006485196275Phase 3Recruiting
- Sponsor
- Mona Raafat Elghamry
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate and dexmedetomidine in None, sponsored by Mona Raafat Elghamry. Primary endpoint: Frequency of cerebral oxygen desaturation. Started Jun 2020; status: recruiting.
02
Drugs
magnesium sulfatedexmedetomidine
Beyond the preview
Go deeper on PACTR202006485196275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006485196275.